Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Lipoproteins & CV Outcomes in Dialysis Patients

J Clin Lipidol; ePub 2017 Dec 26; Kaysen, et al

Low-density lipoprotein (LDL) and apoliporprotein (Apo) B are inversely associated with infectious events in dialysis patients; however, lipoproteins are not associated with cardiovascular outcomes, a recent study found. Researchers examined associations between serum apolipoprotein (Apo) A1, B, C2, C3, high-density lipoprotein (HDL) and LDL cholesterol and triglyceride levels and infectious mortality or hospitalization, CV mortality or hospitalization, and all-cause mortality in 433 prevalent patients receiving hemodialysis (HD). They found:

  • Median follow-up for all-cause mortality was 2.7 years.
  • 179 (41%) patients had an infection-related event.
  • Higher Apo A1, Apo B, and Apo C3 are associated with lower all-cause mortality.
  • Lipoproteins are not associated with CV outcomes.


Kaysen GA, Grimes B, Dalrymple LS, et al. Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis. [Published online ahead of print December 26, 2017]. J Clin Lipidol. doi:10.1016/j.jacl.2017.12.007.

This Week's Must Reads

Improving CV Health in Women Through Provider Collaboration, Circulation; ePub 2018 May 10; Brown, et al

Burden of AF With Risk of Stroke in Paroxysmal AF, JAMA Cardiol; ePub 2018 May 16; Go, et al

OSA & Risk of Hospitalization in Patients with HFpEF, Am J Cardiol; ePub 2018 May 11; Abdullah, et al

Air Pollution Exposure in Pregnancy & Risk of High BP, Hypertension; ePub 2018 May 14; Zhang, et al

Total & CV Mortality After LDL-C Lowering, JAMA; 2018 Apr 17; Navarese, et al

Must Reads in Hypercholesterolemia

Total & CV Mortality After LDL-C Lowering, JAMA; 2018 Apr 17; Navarese, et al

PCSK9 Inhibitors for Tx of Hypercholesterolemia, Ann Pharmacother; ePub 2018 Apr 1; Patel, et al

High-Intensity Statin Use and LDL-C Control, J Clin Lipidol; ePub 2018 Apr 26; Lamprecht Jr, et al

Improving Adherence with ASCVD Interventions, Clin Cardiol; ePub 2018 Apr 17; Fentanes, et al

Lipid Screening in Children with NAFLD, J Pediatr; ePub 2018 Apr 13; Harlow, et al